Alexander Michael Barbaro

Alexander Barbaro practices at Lenox Hill Hospital in New York, New York, part of Northwell Health.

Alexander Barbaro's NPI, 1396278040, was assigned on April 10, 2017. Alexander Barbaro holds New York license 305017.

Alexander Barbaro's primary practice is Lenox Hill Hospital, at 100 East 77th Street, New York, NY 10075 in New York County. The practice phone is (212) 434-2000.

Alexander Barbaro's primary practice is Lenox Hill Hospital in New York, New York, part of Northwell Health. Alexander Barbaro is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Northwell Health Physician Partners.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexander Barbaro practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Alexander Barbaro's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Alexander Barbaro is licensed in New York.

CMS data shows 477 Medicare services from Alexander Barbaro across 8 procedure codes in 2024, for 102 Medicare patients. Medicare paid $31,656 for them.

CMS counts 102 Medicare patients who saw Alexander Barbaro in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alexander Barbaro's median patient age at 70, with 50% women.

In 2024, Alexander Barbaro wrote 108 Medicare Part D claims for 37 patients. 58% of them were for generic drugs. CMS names the drug for 43 of them, across 2 drugs with 11 or more claims each, at $18,728 in total drug cost. In 2020, CMS named 23 claims across 2 drugs.

Alexander Barbaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexander Barbaro as offering telehealth.

Dmand AI links 3 papers to Alexander Barbaro, published from 2018 to 2024. The most frequent topics are Carcinoma, Non-Small-Cell Lung and Lung Neoplasms. Alexander Barbaro's most frequent co-authors are Daniel Jacob Becker, MD, Kenneth Csehak, MD and Lei Deng, MD.

CMS Open Payments shows 4 general payments to Alexander Barbaro from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $242. It also lists 1 research payment totaling $1,560 in 2025, naming 1 clinical trial.